CompletedPhase 3NCT01528449
Babesia Testing in Blood Donors
Studying Babesiosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Imugen
- Principal Investigator
- Philip J Molloy, MD, MDImugen Medical Director
- Intervention
- B.microti diagnostic blood tests(biological)
- Enrollment
- 90116 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2011 – 2014
Study locations (1)
- Imugen, Norwood, Massachusetts, United States
Collaborators
American National Red Cross · Memorial Blood Centers, Minnesota · Rhode Island Blood Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01528449 on ClinicalTrials.govOther trials for Babesiosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06656351B-FREE Chronic Babesiosis Study60 Degrees Pharmaceuticals LLC
- RECRUITINGNCT07345988Human Babesiosis in Metropolitan FranceUniversity Hospital, Strasbourg, France
- RECRUITINGPHASE2NCT06207370Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis60 Degrees Pharmaceuticals LLC